{ "cik": 1906324, "cik_padded": "0001906324", "entityName": "QuidelOrtho Corp", "fiscal_years": [ { "accn": "0001906324-26-000008", "filed": "2026-02-19", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 188200000.0, "cash": 169800000.0, "eps_diluted": -16.69, "free_cash_flow": -83000000.0, "net_income": -1131800000.0, "operating_cash_flow": 105200000.0, "operating_income": -919200000.0, "revenue": 2730200000.0, "stockholders_equity": 1920500000.0, "total_assets": 5769300000.0, "total_liabilities": 3848800000.0 }, "period_end": "2025-12-28", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 2.0040614423327257, "net_margin": -0.41454838473371913, "operating_margin": -0.33667863160208045, "revenue_growth_yoy": -0.018937080024434942, "roa_avg2y": -0.18564902525240098, "roa_period_end": -0.19617631255091605, "roe_avg2y": -0.46148827726809377, "roe_period_end": -0.5893256964332205 } }, { "accn": "0001906324-26-000008", "filed": "2026-02-19", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 195100000.0, "cash": 98300000.0, "eps_diluted": -30.54, "free_cash_flow": -112100000.0, "net_income": -2052000000.0, "operating_cash_flow": 83000000.0, "operating_income": -1960900000.0, "revenue": 2782900000.0, "stockholders_equity": 2984500000.0, "total_assets": 6423600000.0, "total_liabilities": 3439100000.0 }, "period_end": "2024-12-29", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.15232032166192, "net_margin": -0.7373603075927988, "operating_margin": -0.7046246721046391, "revenue_growth_yoy": -0.07168590299553006, "roa_avg2y": -0.2738428072891297, "roa_period_end": -0.319447039043527, "roe_avg2y": -0.5136163396075291, "roe_period_end": -0.6875523538281118 } }, { "accn": "0001906324-26-000008", "filed": "2026-02-19", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 7200000.0, "capex": 209300000.0, "cash": 118900000.0, "eps_diluted": -0.15, "free_cash_flow": 70900000.0, "net_income": -10100000.0, "operating_cash_flow": 280200000.0, "operating_income": 139100000.0, "revenue": 2997800000.0, "stockholders_equity": 5005900000.0, "total_assets": 8563100000.0, "total_liabilities": 3557200000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.710601490241515, "net_margin": -0.0033691373674027626, "operating_margin": 0.04640069384215091, "revenue_growth_yoy": 0.7648651830919581, "roa_avg2y": -0.0018374494019193159, "roa_period_end": -0.0011794793941446438, "roe_avg2y": -0.00291263535823973, "roe_period_end": -0.002017619209332987 } }, { "accn": "0001906324-25-000035", "filed": "2025-02-27", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 103500000.0, "capex": 292800000.0, "cash": 802800000.0, "eps_diluted": 16.43, "free_cash_flow": 513100000.0, "net_income": 704200000.0, "operating_cash_flow": 805900000.0, "operating_income": 906000000.0, "revenue": 1698600000.0, "stockholders_equity": 1929400000.0, "total_assets": 2430400000.0, "total_liabilities": 501000000.0 }, "period_end": "2022-01-02", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.25966621747693586, "net_margin": 0.41457671023195575, "operating_margin": 0.5333804309431296, "revenue_growth_yoy": 0.022206174399711138, "roa_period_end": 0.2897465437788018, "roe_avg2y": 0.43174642101713623, "roe_period_end": 0.3649839328288587 } }, { "accn": "0001906324-24-000043", "filed": "2024-08-01", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD" }, "fundamentals": { "buybacks": 43700000.0, "capex": 64900000.0, "eps_diluted": 18.6, "free_cash_flow": 564800000.0, "net_income": 810300000.0, "operating_cash_flow": 629700000.0, "operating_income": 1060300000.0, "revenue": 1661700000.0, "stockholders_equity": 1332700000.0 }, "period_end": "2021-01-03", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "roe_period_end": "ratio" }, "ratios": { "net_margin": 0.48763314677739666, "operating_margin": 0.6380814828188001, "roe_period_end": 0.6080138065581151 } }, { "accn": "0001906324-23-000014", "filed": "2023-02-23", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "stockholders_equity": "USD" }, "fundamentals": { "stockholders_equity": 559900000.0 }, "period_end": "2019-12-29", "ratios": {} } ], "latest_filing": { "accn": "0001906324-26-000008", "filed": "2026-02-19", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2835", "sic_description": "In Vitro & In Vivo Diagnostic Substances", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001906324.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001906324.json" }, "ticker": "QDEL" }